Barriers to implementing pharmacoeconomics: interview study-Reference-Cited by-同舟云学术

Barriers to implementing pharmacoeconomics: interview study

Published:2020-05-29 Issue:1 Volume:21 Page:93-104
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Alefan Qais¹,Hamdouni Esra’a¹,Alhamad Hamza²,Mukattash Tareq¹^ORCID,Rascati Karen³

Affiliation:

1. Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan

2. Department of Pharmacy Practice, Faculty of Pharmacy, Zarqa University, Zarqa, Jordan

3. Health Outcomes & Pharmacy Practice, The University of Texas at Austin, Austin, TX, USA

Funder

Deanship of Research/Jordan University of Science and Technology

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1766969

Reference54 articles.

1. Comprehensive assessment of Jordan’s health information system. World Health Organization. Regional Office for the Eastern Mediterranean. 2016 [cited 2020 Apr 25]. Available from: http://applications.emro.who.int/docs/9789290222583-eng.pdf?ua=1

2. Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status

3. Jordan High Health Council. Jordan National Health Account (NHA). The Technical Report No. 6, 2016. 2013 [cited 2020 Apr 25]. Available from: www.hhc.gov.jo

4. Jordan Food and Drug Administration [homepage]. Amman (Jordan): The Administration; [cited 2020 Apr 25]. Available from: www.jfda.jo

5. The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions;Value in Health Regional Issues;2022-11

2. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries;International Journal of Environmental Research and Public Health;2022-06-27

3. A systematic review of economic evaluations of vaccines in Middle East and North Africa countries: is existing evidence good enough to support policy decision-making?;Expert Review of Pharmacoeconomics & Outcomes Research;2021-07-28